Vax Trials
Ciudad de Panama, Panama
Purpose
to assess the safety, reactogenicity, immunogenicity and impact on intestinal shedding of 1 dose of a monovalent type 2 high dose inactivated poliovirus vaccine compared to a licensed trivalent inactivated poliovirus vaccine when given concomitantly with bOPV to infants early in life
Division
Global Development
Date
October 2013
Region Served
GLOBAL
Committed amount
$1,475,832
Grant topic
Polio
Duration (months)
27
Grantee location
Ciudad de Panama, Panama
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.